Literature DB >> 26674943

Family Planning Practices, Programmes and Policies in India Including Implants and Injectables with a Special Focus on Jharkhand, India: A Brief Review.

Janmejaya Samal1, Ranjit Kumar Dehury2.   

Abstract

The National Family Health Survey (NFHS)-3 clearly delineates that the usage of contraceptive practices has increased considerably but is more inclined toward terminal methods of contraception especially the female sterilization. The fact is also evident from various studies carried out from time to time in different Indian states. Given the context we carried out a short review to understand the family planning practices, programs and policies in India including implants and injectable contraceptives with a special focus on the state of Jharkhand. We found that among the reversible methods IUCD (intra uterine contraceptive devices), OC (oral contraceptive) pills and condoms are the most commonly used methods. In this review, in addition to national picture, we specially focused on the state of Jharkhand owing to its very gloomy picture of family planning practices as per NFHS -3 reports. The current usage of any methods of contraception in Jharkhand is only 35.7% out of which terminal methods especially female sterilization accounts to 23.4% and male sterilization being only 0.4%. Similar picture is also reflected in the conventional methods such as; IUCD-0.6%, oral pill -3.8% and condom-2.7%. Compared to the national figure the unmet need for family planning in Jharkhand is also relatively high for the conventional reversible methods than that of terminal methods which is 11.9 and 11.3 respectively. Injectable contraceptives are available only through private or social marketing channels, because of which their use is limited. The studies carried out in different Indian states show improvement in contraceptive prevalence but the same needs further improvement.

Keywords:  Contraceptive; Female sterilization; Prevalence; Reversible methods

Year:  2015        PMID: 26674943      PMCID: PMC4668441          DOI: 10.7860/JCDR/2015/16152.6714

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  9 in total

1.  Transition from Norplant to Jadelle in a clinic with extensive experience providing contraceptive implants.

Authors:  Vivian Brache; Anibal Faundes; Francisco Alvarez; Ana-Gloria García
Journal:  Contraception       Date:  2006-01-03       Impact factor: 3.375

Review 2.  Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy.

Authors:  J Power; R French; F Cowan
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

3.  Family planning practices prior to the acceptance of tubectomy: a study among women attending a maternity home in bangalore,india.

Authors:  Srividya V; Jayanth Kumar
Journal:  J Clin Diagn Res       Date:  2013-08-01

4.  Adoption and continuation of contraception following medical or surgical abortion in Bihar and Jharkhand, India.

Authors:  Shveta Kalyanwala; Rajib Acharya; A J Francis Zavier
Journal:  Int J Gynaecol Obstet       Date:  2012-09       Impact factor: 3.561

5.  A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects.

Authors:  G W Sang; Q X Shao; R S Ge; J L Ge; J K Chen; S Song; K J Fang; M L He; S Y Luo; S F Chen
Journal:  Contraception       Date:  1995-03       Impact factor: 3.375

Review 6.  Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.

Authors:  S Koetsawang
Journal:  Contraception       Date:  1994-04       Impact factor: 3.375

7.  The introduction of Cyclofem into national family planning programmes: experience from studies in Indonesia, Jamaica, Mexico, Thailand and Tunisia. Task Force on Research on Introduction and Transfer of Technologies for Fertility Regulation, Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland.

Authors:  P E Hall
Journal:  Contraception       Date:  1994-05       Impact factor: 3.375

8.  Comparative evaluation of contraceptive efficacy of norethisterone oenanthate (200 mg) injectable contraceptive given every two or three monthly. Indian Council of Medical Research Task Force on Hormonal Contraception.

Authors:  S K Banerjee; R Baweja; R V Bhatt; A Chatterjee; S D Choudhury; B Coyaji; A D Engineer; M P Gogoi; V Hingorani
Journal:  Contraception       Date:  1984-12       Impact factor: 3.375

9.  Evaluation of a multi-pronged intervention to improve access to safe abortion care in two districts in Jharkhand.

Authors:  Sushanta K Banerjee; Kathryn L Andersen; Traci L Baird; Bela Ganatra; Sangeeta Batra; Janardan Warvadekar
Journal:  BMC Health Serv Res       Date:  2014-05-21       Impact factor: 2.655

  9 in total
  2 in total

1.  Mobile Helpline and Reversible Contraception: Lessons From a Controlled Before-and-After Study in Rural India.

Authors:  Sangita Kulathinal; Bijoy Joseph; Minna Säävälä
Journal:  JMIR Mhealth Uhealth       Date:  2019-08-09       Impact factor: 4.773

2.  Measuring quality of family planning counselling and its effects on uptake of contraceptives in public health facilities in Uttar Pradesh, India: A cross-sectional analysis.

Authors:  Arnab K Dey; Sarah Averbach; Anvita Dixit; Amit Chakraverty; Nabamallika Dehingia; Dharmendra Chandurkar; Kultar Singh; Vikas Choudhry; Jay G Silverman; Anita Raj
Journal:  PLoS One       Date:  2021-05-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.